BONE MARROW LEUKAEMIC CELL INFILTRATION

BONE MARROW LEUKAEMIC CELL INFILTRATION was reported 82 times

BONE MARROW LEUKAEMIC CELL INFILTRATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD22-directed Immunoconjugate [EPC] 5 0.0017
1 Echinocandin Antifungal [EPC] 4 0.0005
2 Asparagine-specific Enzyme [EPC] 3 0.0002
3 BCL-2 Inhibitor [EPC] 9 0.0001
4 Topoisomerase Inhibitor [EPC] 6 0.0001
5 Lipid-based Polyene Antifungal [EPC] 1 0.0001
6 Nucleoside Metabolic Inhibitor [EPC] 21 0.0001
7 Alkylating Drug [EPC] 18 0.0001
8 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
9 Prostaglandin E1 Analog [EPC] 1 0.0001
10 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
11 Polyene Antifungal [EPC] 2 0.0000
12 Bile Acid [EPC] 1 0.0000
13 Leukocyte Growth Factor [EPC] 6 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 17 0.0000
15 Fluoroquinolone Antibacterial [EPC] 5 0.0000
16 Iron Chelator [EPC] 1 0.0000
17 Penem Antibacterial [EPC] 1 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
20 Protease Inhibitor [EPC] 1 0.0000
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
22 Purine Antimetabolite [EPC] 2 0.0000
23 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
24 Corticosteroid [EPC] 20 0.0000
25 Glycopeptide Antibacterial [EPC] 1 0.0000
26 Cardiac Glycoside [EPC] 1 0.0000
27 Azole Antifungal [EPC] 2 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
29 Platinum-based Drug [EPC] 3 0.0000
30 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
31 Aminosalicylate [EPC] 1 0.0000
32 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
33 Proteasome Inhibitor [EPC] 1 0.0000
34 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
35 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
36 Microtubule Inhibitor [EPC] 1 0.0000
37 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
38 Kinase Inhibitor [EPC] 2 0.0000
39 Thalidomide Analog [EPC] 1 0.0000
40 Tumor Necrosis Factor Blocker [EPC] 1 0.0000